Top Markets
Coin of the day
Artrya Limited Artrya Limited

Artrya Limited

AYA
Rank in Stocks #13455
Artrya Limited is a medical technology firm that harnesses artificial... Artrya Limited is a medical technology firm that harnesses artificial intelligence (AI) to pinpoint individuals at risk of developing coronary artery disease. The company's key offering is Salix, a cloud-based software application. Salix leverages Artrya's proprietary AI to automate the identification of coronary artery disease through the analysis of coronary computed tomography angiography (CCTA) scans. Founded in 2018, the company is headquartered in West Perth, Australia.
Share Price
$2.99
Market Cap
$487.33M
Change (1 day)
-10.74%
Change (1 year)
114.71%
Country
AU
Trade Artrya Limited (AYA)

Category

P/B ratio for Artrya Limited (AYA)
P/B ratio as of 2026 TTM: 0
According to Artrya Limited latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Artrya Limited from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors